BioCryst Pharmaceuticals.

PositionDURHAM

Robert Ingram was named chairman of BioCryst Pharmaceuticals. Ingram, the former CEO of Glaxo-Wellcome and a partner of Durham's Hatteras Venture Partners, replaces George Abercrombie, who will remain a director. BioCryst develops drugs for rare diseases...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT